On May 29, 2019, Ocular Therapeutix, Inc. entered into a transition, separation and release of claims agreementwith Dr. Amarpreet S. Sawhney based on a mutual agreement not to renew Dr. Sawhney’s Employment Agreement with the Company, dated as of June 24, 2014, as amended as of June 20, 2017 and August 6, 2018. Pursuant to the Transition Agreement, Dr. Sawhney has resigned from his role as Chairman of the Board of Directorsof the Company and any and all other positions he holds as an officer, employee or member of the Board of Directors of the Company, effective as of July 26, 2019. From May 29, 2019 to the Separation Date, Dr. Sawhney has agreed to continue to serve as Chairman of the Board and as an at-will employee of the Company.